GlassScriptPhysician profile
Tracy Hilburn
NPI 1659725430
$3,693.88
in general payments reported to CMS, 2019-2025
31 companies · $1,647 in 2025
The $1,647 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $574 · 2024: $1,473 · 2025: $1,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,693.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $547.22 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $541.55 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $350.26 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $219.58 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $210.17 | 2023-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $172.88 | 2023-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $154.78 | 2023-2025 | Rexulti |
| Corium, LLC | $145.85 | 2023-2025 | Azstarys |
| Amgen INC. | $125.95 | 2024-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.83 | 2023-2025 | Jardiance |
| Exact Sciences Corporation | $117.21 | 2023-2025 | Cologuard Collection Kit |
| Ironshore Pharmaceuticals INC. | $114.81 | 2023-2024 | Jornay Pm |
| Axsome Therapeutics, INC. | $109.14 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $103.24 | 2024-2025 | |
| Harmony Biosciences LLC | $102.40 | 2023-2024 | Wakix |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $86.58 | 2024-2025 | Trintellix |
| Aimmune Therapeutics, INC. | $76.56 | 2024-2025 | Zenpep |
| Pfizer INC. | $68.07 | 2024-2025 | |
| Electromed, INC. | $52.32 | 2025 | Smartvest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.05 | 2024 | Xifaxan, Trulance |
| Tonix Medicines, INC. | $31.37 | 2025 | Tonmya |
| Collegium Pharmaceutical, INC. | $30.36 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $27.96 | 2023-2025 | Trelegy Ellipta, Bexsero, Rotarix |
| Lundbeck LLC | $26.60 | 2025 | Rexulti |
| Mylan Specialty L.P. | $23.51 | 2023 | Yupelri |
| Inspire Medical Systems, INC. | $18.38 | 2025 | Inspire |
| Astellas Pharma US INC | $17.31 | 2023 | Veozah |
| Verona Pharma, INC. | $16.92 | 2025 | Ohtuvayre |
| Antares Pharma, INC. | $15.88 | 2025 | Xyosted |
| Organon LLC | $15.23 | 2025 | Nexplanon |
| Idorsia Pharmaceuticals US INC | $14.91 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Hilburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.